Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction

04-Jan-2018

A recent article on Rocket Pharma merger and NASDAQ Listing:

Rocket Pharmaceuticals, Ltd., a leading U.S.-based multi-platform gene therapy company addressing challenging rare diseases, today announced the completion of its merger with Inotek Pharmaceuticals Corporation

Rocket utilizes a multi-platform development approach that leverages the well-established lentiviralvector (LVV) and adeno-associated viral vector (AAV) gene delivery methods and is initially targeting devastating rare diseases in children that lead to early mortality in the absence of bone marrow transplant or other invasive procedures.

Read the full article